Phase II Study of Combination Chemotherapy with Etoposide and Ifosfamide in Patients with Heavily Pretreated Recurrent or Persistent Epithelial Ovarian Cancer

The aim of this trial was to investigate the efficacy and toxicity of combination chemotherapy with etoposide and ifosfamide (ETI) in the management of heavily pretreated recurrent or persistent epithelial ovarian cancer (EOC). Patients with recurrent or persistent EOC who had measurable disease and...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Kang, Heeseok, Kim, Tae-Joong, Choi, Chel Hun, Lee, Jeong-Won, Lee, Je-Ho, Bae, Duk-Soo, Kim, Byoung-Gie
פורמט: Artigo
שפה:Inglês
יצא לאור: The Korean Academy of Medical Sciences 2009
נושאים:
Original Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2752782/
https://ncbi.nlm.nih.gov/pubmed/19794997
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2009.24.5.945
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים